Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of receipt of No-objection Letter for reclassification of shareholding from Promoter and Promoter Group category to Public category, in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Emcure Pharmaceuticals has received a no-objection letter from the stock exchange to reclassify certain shareholders from the 'Promoter and Promoter Group' category to the 'Public' category. The reclassification is being done under Regulation 31A of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. This means some shareholders who were earlier classified as promoters will now be treated as public shareholders. The change relates only to the classification of shareholding and does not involve any actual sale or purchase of shares.
The promoter group's effective shareholding will reduce on paper while public shareholding will increase. This is a classification change, not a real transfer of ownership, so it should not directly affect the stock price, but it changes the promoter vs public holding ratios reported by the company.